"Somos, en total, más de 3.000 profesionales y nuestra razón de ser es el bienestar y la salud de la población que cuidamos."

During the past decade, Complejo Hospitalario Torrecárdenas conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 8 clinical trials were completed, i.e. on average, 27.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 4 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complejo Hospitalario Torrecárdenas" #1 sponsor was "Fundación Pública Andaluza Progreso y Salud" with 6 trials, followed by "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla" with 4 trials sponsored, "Celgene" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular" with 2 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario Torrecárdenas" #1 collaborator was "Abbott Medical Devices" with 2 trials as a collaborator, "B.Braun Surgical SA" with 2 trials as a collaborator, "Dynamic Science S.L." with 2 trials as a collaborator, "Hospital San Carlos, Madrid" with 2 trials as a collaborator and "Instituto de Salud Carlos III" with 2 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 64 trials.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario Torrecárdenas" are "Colorectal Cancer" (2 trials), "Epithelial Ovarian Cancer" (2 trials), "Fallopian Tube Cancer" (2 trials), "HIV Infection" (2 trials) and "NASH - Nonalcoholic Steatohepatitis" (2 trials). Many other conditions were trialed in "Complejo Hospitalario Torrecárdenas" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario Torrecárdenas" are "Drug" (31 trials), "Device" (6 trials), "Other" (5 trials), "Procedure" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Coronary angioplasty using the paclitaxel-eluting balloon" (2 trials), "Cytarabine" (2 trials), "13-valent pneumococcal conjugate vaccine" (1 trials) and "6-Mercaptopurine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario Torrecárdenas" are 50 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Complejo Hospitalario Torrecárdenas". undefined are not yet recruiting, 12 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Complejo Hospitalario Torrecárdenas, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario Torrecárdenas, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 4 trials that are defined as “Not Applicable".

Complejo Hospitalario Torrecárdenas has several departments that took part in Clinical trials: "Complejo Hospitalario Torrecardenas; Servicio de Oncologia" - 2 trials